Global Radiopharmaceuticals for PET and SPECT Imaging Market Growth (Status and Outlook) 2026-2032
The global Radiopharmaceuticals for PET and SPECT Imaging market size is predicted to grow from US$ 6848 million in 2025 to US$ 10922 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.
Radiopharmaceuticals for PET and SPECT Imaging are specialized radioactive compounds used as diagnostic tracers in nuclear medicine imaging procedures. These agents consist of a biologically active molecule labeled with a radionuclide, allowing physicians to visualize physiological, biochemical, and molecular processes within the body. In Positron Emission Tomography (PET), commonly used isotopes include fluorine-18, carbon-11, gallium-68, and zirconium-89, while Single Photon Emission Computed Tomography (SPECT) primarily utilizes technetium-99m, iodine-123, and thallium-201. These radiopharmaceuticals are widely employed in oncology, cardiology, neurology, and infection imaging, enabling early disease detection, diagnosis, treatment planning, and therapeutic monitoring.
The global Fluorine-18 market is experiencing steady expansion, driven primarily by the rising prevalence of chronic diseases such as cancer, Alzheimer?s, and cardiovascular disorders. As the gold standard radionuclide for Positron Emission Tomography (PET) imaging, Fluorine-18 benefits from its 110-minute half-life, which allows for efficient centralized production and distribution. Market growth is further propelled by the adoption of precision medicine, the expansion of cyclotron infrastructure, and the continuous development of novel radiotracers beyond traditional FDG. While North America remains the dominant region due to its advanced healthcare infrastructure and high utilization of PET/CT systems, the Asia-Pacific region is emerging as the fastest-growing market, fueled by significant investments in nuclear medicine and increasing healthcare accessibility. Future market trends emphasize the integration of AI in diagnostic imaging, the rise of 'theranostics,' and a strategic shift toward localized, hospital-adjacent cyclotron facilities to optimize supply chain efficiency.
LPI (LP Information)' newest research report, the ?Radiopharmaceuticals for PET and SPECT Imaging Industry Forecast? looks at past sales and reviews total world Radiopharmaceuticals for PET and SPECT Imaging sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiopharmaceuticals for PET and SPECT Imaging sales for 2026 through 2032. With Radiopharmaceuticals for PET and SPECT Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceuticals for PET and SPECT Imaging industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceuticals for PET and SPECT Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiopharmaceuticals for PET and SPECT Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Radiopharmaceuticals for PET and SPECT Imaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceuticals for PET and SPECT Imaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceuticals for PET and SPECT Imaging.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals for PET and SPECT Imaging market by product type, application, key players and key regions and countries.
Segmentation by Type:
Radiopharmaceuticals for PET and SPECT Imaging are specialized radioactive compounds used as diagnostic tracers in nuclear medicine imaging procedures. These agents consist of a biologically active molecule labeled with a radionuclide, allowing physicians to visualize physiological, biochemical, and molecular processes within the body. In Positron Emission Tomography (PET), commonly used isotopes include fluorine-18, carbon-11, gallium-68, and zirconium-89, while Single Photon Emission Computed Tomography (SPECT) primarily utilizes technetium-99m, iodine-123, and thallium-201. These radiopharmaceuticals are widely employed in oncology, cardiology, neurology, and infection imaging, enabling early disease detection, diagnosis, treatment planning, and therapeutic monitoring.
The global Fluorine-18 market is experiencing steady expansion, driven primarily by the rising prevalence of chronic diseases such as cancer, Alzheimer?s, and cardiovascular disorders. As the gold standard radionuclide for Positron Emission Tomography (PET) imaging, Fluorine-18 benefits from its 110-minute half-life, which allows for efficient centralized production and distribution. Market growth is further propelled by the adoption of precision medicine, the expansion of cyclotron infrastructure, and the continuous development of novel radiotracers beyond traditional FDG. While North America remains the dominant region due to its advanced healthcare infrastructure and high utilization of PET/CT systems, the Asia-Pacific region is emerging as the fastest-growing market, fueled by significant investments in nuclear medicine and increasing healthcare accessibility. Future market trends emphasize the integration of AI in diagnostic imaging, the rise of 'theranostics,' and a strategic shift toward localized, hospital-adjacent cyclotron facilities to optimize supply chain efficiency.
LPI (LP Information)' newest research report, the ?Radiopharmaceuticals for PET and SPECT Imaging Industry Forecast? looks at past sales and reviews total world Radiopharmaceuticals for PET and SPECT Imaging sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiopharmaceuticals for PET and SPECT Imaging sales for 2026 through 2032. With Radiopharmaceuticals for PET and SPECT Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceuticals for PET and SPECT Imaging industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceuticals for PET and SPECT Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiopharmaceuticals for PET and SPECT Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Radiopharmaceuticals for PET and SPECT Imaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceuticals for PET and SPECT Imaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceuticals for PET and SPECT Imaging.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals for PET and SPECT Imaging market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Positron Emitters
- Gamma Emitters
- Cyclotron-produced
- Reactor/Generator-produced
- High Specific Activity
- Low Specific Activity
- Hospital
- Medical Imaging Center
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ANSTO
- Rosatom
- Eckert & Ziegler
- CNNC
- Curium Pharma
- GE HealthCare
- Jubilant Radiopharma
- Cardinal Health
- IBA
- Sumitomo Heavy Industries
- Sinotau
- Nueclear Healthcare
- DC Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size (2021-2032)
2.1.2 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radiopharmaceuticals for PET and SPECT Imaging by Country/Region (2021, 2025 & 2032)
2.2 Radiopharmaceuticals for PET and SPECT Imaging Segment by Type
2.2.1 Positron Emitters
2.2.2 Gamma Emitters
2.2.3 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type
2.2.3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
2.3 Radiopharmaceuticals for PET and SPECT Imaging Segment by Produced
2.3.1 Cyclotron-produced
2.3.2 Reactor/Generator-produced
2.3.3 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Produced
2.3.3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Produced (2021 VS 2025 VS 2032)
2.3.3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Produced (2021-2026)
2.4 Radiopharmaceuticals for PET and SPECT Imaging Segment by Specific Activity
2.4.1 High Specific Activity
2.4.2 Low Specific Activity
2.4.3 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Specific Activity
2.4.3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Specific Activity (2021 VS 2025 VS 2032)
2.4.3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Specific Activity (2021-2026)
2.5 Radiopharmaceuticals for PET and SPECT Imaging Segment by Application
2.5.1 Hospital
2.5.2 Medical Imaging Center
2.5.3 Other
2.5.4 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application
2.5.4.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
3 RADIOPHARMACEUTICALS FOR PET AND SPECT IMAGING MARKET SIZE BY PLAYER
3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Player
3.1.1 Global Radiopharmaceuticals for PET and SPECT Imaging Revenue by Player (2021-2026)
3.1.2 Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Player (2021-2026)
3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS FOR PET AND SPECT IMAGING BY REGION
4.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026)
4.2 Global Radiopharmaceuticals for PET and SPECT Imaging Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
4.4 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
4.5 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
4.6 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026)
5.2 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
5.3 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026)
6.2 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
6.3 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026)
7.2 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
7.3 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging by Region (2021-2026)
8.2 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
8.3 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOPHARMACEUTICALS FOR PET AND SPECT IMAGING MARKET FORECAST
10.1 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.1.1 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.1.2 Americas Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.1.3 APAC Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.1.4 Europe Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.1.5 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2 Americas Radiopharmaceuticals for PET and SPECT Imaging Forecast by Country (2027-2032)
10.2.1 United States Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2.2 Canada Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2.3 Mexico Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2.4 Brazil Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3 APAC Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.3.1 China Radiopharmaceuticals for PET and SPECT Imaging Market Forecast
10.3.2 Japan Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.3 Korea Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.4 Southeast Asia Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.5 India Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.6 Australia Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4 Europe Radiopharmaceuticals for PET and SPECT Imaging Forecast by Country (2027-2032)
10.4.1 Germany Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.2 France Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.3 UK Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.4 Italy Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.5 Russia Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.5.1 Egypt Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5.2 South Africa Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5.3 Israel Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5.4 Turkey Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.6 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Type (2027-2032)
10.7 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
11 KEY PLAYERS ANALYSIS
11.1 ANSTO
11.1.1 ANSTO Company Information
11.1.2 ANSTO Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.1.3 ANSTO Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ANSTO Main Business Overview
11.1.5 ANSTO Latest Developments
11.2 Rosatom
11.2.1 Rosatom Company Information
11.2.2 Rosatom Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.2.3 Rosatom Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Rosatom Main Business Overview
11.2.5 Rosatom Latest Developments
11.3 Eckert & Ziegler
11.3.1 Eckert & Ziegler Company Information
11.3.2 Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.3.3 Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Eckert & Ziegler Main Business Overview
11.3.5 Eckert & Ziegler Latest Developments
11.4 CNNC
11.4.1 CNNC Company Information
11.4.2 CNNC Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.4.3 CNNC Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 CNNC Main Business Overview
11.4.5 CNNC Latest Developments
11.5 Curium Pharma
11.5.1 Curium Pharma Company Information
11.5.2 Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.5.3 Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Curium Pharma Main Business Overview
11.5.5 Curium Pharma Latest Developments
11.6 GE HealthCare
11.6.1 GE HealthCare Company Information
11.6.2 GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.6.3 GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GE HealthCare Main Business Overview
11.6.5 GE HealthCare Latest Developments
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Information
11.7.2 Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.7.3 Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Jubilant Radiopharma Main Business Overview
11.7.5 Jubilant Radiopharma Latest Developments
11.8 Cardinal Health
11.8.1 Cardinal Health Company Information
11.8.2 Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.8.3 Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cardinal Health Main Business Overview
11.8.5 Cardinal Health Latest Developments
11.9 IBA
11.9.1 IBA Company Information
11.9.2 IBA Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.9.3 IBA Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 IBA Main Business Overview
11.9.5 IBA Latest Developments
11.10 Sumitomo Heavy Industries
11.10.1 Sumitomo Heavy Industries Company Information
11.10.2 Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.10.3 Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Sumitomo Heavy Industries Main Business Overview
11.10.5 Sumitomo Heavy Industries Latest Developments
11.11 Sinotau
11.11.1 Sinotau Company Information
11.11.2 Sinotau Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.11.3 Sinotau Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Sinotau Main Business Overview
11.11.5 Sinotau Latest Developments
11.12 Nueclear Healthcare
11.12.1 Nueclear Healthcare Company Information
11.12.2 Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.12.3 Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Nueclear Healthcare Main Business Overview
11.12.5 Nueclear Healthcare Latest Developments
11.13 DC Pharma
11.13.1 DC Pharma Company Information
11.13.2 DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.13.3 DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 DC Pharma Main Business Overview
11.13.5 DC Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size (2021-2032)
2.1.2 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radiopharmaceuticals for PET and SPECT Imaging by Country/Region (2021, 2025 & 2032)
2.2 Radiopharmaceuticals for PET and SPECT Imaging Segment by Type
2.2.1 Positron Emitters
2.2.2 Gamma Emitters
2.2.3 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type
2.2.3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
2.3 Radiopharmaceuticals for PET and SPECT Imaging Segment by Produced
2.3.1 Cyclotron-produced
2.3.2 Reactor/Generator-produced
2.3.3 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Produced
2.3.3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Produced (2021 VS 2025 VS 2032)
2.3.3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Produced (2021-2026)
2.4 Radiopharmaceuticals for PET and SPECT Imaging Segment by Specific Activity
2.4.1 High Specific Activity
2.4.2 Low Specific Activity
2.4.3 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Specific Activity
2.4.3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Specific Activity (2021 VS 2025 VS 2032)
2.4.3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Specific Activity (2021-2026)
2.5 Radiopharmaceuticals for PET and SPECT Imaging Segment by Application
2.5.1 Hospital
2.5.2 Medical Imaging Center
2.5.3 Other
2.5.4 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application
2.5.4.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
3 RADIOPHARMACEUTICALS FOR PET AND SPECT IMAGING MARKET SIZE BY PLAYER
3.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Player
3.1.1 Global Radiopharmaceuticals for PET and SPECT Imaging Revenue by Player (2021-2026)
3.1.2 Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Player (2021-2026)
3.2 Global Radiopharmaceuticals for PET and SPECT Imaging Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS FOR PET AND SPECT IMAGING BY REGION
4.1 Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026)
4.2 Global Radiopharmaceuticals for PET and SPECT Imaging Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
4.4 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
4.5 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
4.6 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026)
5.2 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
5.3 Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026)
6.2 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
6.3 APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026)
7.2 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
7.3 Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging by Region (2021-2026)
8.2 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026)
8.3 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOPHARMACEUTICALS FOR PET AND SPECT IMAGING MARKET FORECAST
10.1 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.1.1 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.1.2 Americas Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.1.3 APAC Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.1.4 Europe Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.1.5 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2 Americas Radiopharmaceuticals for PET and SPECT Imaging Forecast by Country (2027-2032)
10.2.1 United States Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2.2 Canada Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2.3 Mexico Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.2.4 Brazil Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3 APAC Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.3.1 China Radiopharmaceuticals for PET and SPECT Imaging Market Forecast
10.3.2 Japan Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.3 Korea Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.4 Southeast Asia Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.5 India Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.3.6 Australia Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4 Europe Radiopharmaceuticals for PET and SPECT Imaging Forecast by Country (2027-2032)
10.4.1 Germany Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.2 France Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.3 UK Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.4 Italy Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.4.5 Russia Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5 Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Forecast by Region (2027-2032)
10.5.1 Egypt Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5.2 South Africa Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5.3 Israel Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.5.4 Turkey Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
10.6 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Type (2027-2032)
10.7 Global Radiopharmaceuticals for PET and SPECT Imaging Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radiopharmaceuticals for PET and SPECT Imaging Forecast
11 KEY PLAYERS ANALYSIS
11.1 ANSTO
11.1.1 ANSTO Company Information
11.1.2 ANSTO Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.1.3 ANSTO Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ANSTO Main Business Overview
11.1.5 ANSTO Latest Developments
11.2 Rosatom
11.2.1 Rosatom Company Information
11.2.2 Rosatom Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.2.3 Rosatom Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Rosatom Main Business Overview
11.2.5 Rosatom Latest Developments
11.3 Eckert & Ziegler
11.3.1 Eckert & Ziegler Company Information
11.3.2 Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.3.3 Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Eckert & Ziegler Main Business Overview
11.3.5 Eckert & Ziegler Latest Developments
11.4 CNNC
11.4.1 CNNC Company Information
11.4.2 CNNC Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.4.3 CNNC Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 CNNC Main Business Overview
11.4.5 CNNC Latest Developments
11.5 Curium Pharma
11.5.1 Curium Pharma Company Information
11.5.2 Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.5.3 Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Curium Pharma Main Business Overview
11.5.5 Curium Pharma Latest Developments
11.6 GE HealthCare
11.6.1 GE HealthCare Company Information
11.6.2 GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.6.3 GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GE HealthCare Main Business Overview
11.6.5 GE HealthCare Latest Developments
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Information
11.7.2 Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.7.3 Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Jubilant Radiopharma Main Business Overview
11.7.5 Jubilant Radiopharma Latest Developments
11.8 Cardinal Health
11.8.1 Cardinal Health Company Information
11.8.2 Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.8.3 Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cardinal Health Main Business Overview
11.8.5 Cardinal Health Latest Developments
11.9 IBA
11.9.1 IBA Company Information
11.9.2 IBA Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.9.3 IBA Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 IBA Main Business Overview
11.9.5 IBA Latest Developments
11.10 Sumitomo Heavy Industries
11.10.1 Sumitomo Heavy Industries Company Information
11.10.2 Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.10.3 Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Sumitomo Heavy Industries Main Business Overview
11.10.5 Sumitomo Heavy Industries Latest Developments
11.11 Sinotau
11.11.1 Sinotau Company Information
11.11.2 Sinotau Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.11.3 Sinotau Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Sinotau Main Business Overview
11.11.5 Sinotau Latest Developments
11.12 Nueclear Healthcare
11.12.1 Nueclear Healthcare Company Information
11.12.2 Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.12.3 Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Nueclear Healthcare Main Business Overview
11.12.5 Nueclear Healthcare Latest Developments
11.13 DC Pharma
11.13.1 DC Pharma Company Information
11.13.2 DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
11.13.3 DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 DC Pharma Main Business Overview
11.13.5 DC Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radiopharmaceuticals for PET and SPECT Imaging Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Positron Emitters
Table 4. Major Players of Gamma Emitters
Table 5. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Cyclotron-produced
Table 9. Major Players of Reactor/Generator-produced
Table 10. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Produced (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Produced (2021-2026) & ($ millions)
Table 12. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Produced (2021-2026)
Table 13. Major Players of High Specific Activity
Table 14. Major Players of Low Specific Activity
Table 15. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Specific Activity (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Specific Activity (2021-2026) & ($ millions)
Table 17. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Specific Activity (2021-2026)
Table 18. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Table 21. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Player (2021-2026)
Table 23. Radiopharmaceuticals for PET and SPECT Imaging Key Players Head office and Products Offered
Table 24. Radiopharmaceuticals for PET and SPECT Imaging Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Table 29. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Country (2021-2026)
Table 33. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Table 35. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Table 37. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Table 39. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Country (2021-2026)
Table 43. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals for PET and SPECT Imaging
Table 49. Key Market Challenges & Risks of Radiopharmaceuticals for PET and SPECT Imaging
Table 50. Key Industry Trends of Radiopharmaceuticals for PET and SPECT Imaging
Table 51. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. ANSTO Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 56. ANSTO Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 57. ANSTO Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. ANSTO Main Business
Table 59. ANSTO Latest Developments
Table 60. Rosatom Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 61. Rosatom Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 62. Rosatom Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Rosatom Main Business
Table 64. Rosatom Latest Developments
Table 65. Eckert & Ziegler Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 66. Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 67. Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Eckert & Ziegler Main Business
Table 69. Eckert & Ziegler Latest Developments
Table 70. CNNC Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 71. CNNC Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 72. CNNC Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. CNNC Main Business
Table 74. CNNC Latest Developments
Table 75. Curium Pharma Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 76. Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 77. Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Curium Pharma Main Business
Table 79. Curium Pharma Latest Developments
Table 80. GE HealthCare Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 81. GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 82. GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. GE HealthCare Main Business
Table 84. GE HealthCare Latest Developments
Table 85. Jubilant Radiopharma Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 86. Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 87. Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Jubilant Radiopharma Main Business
Table 89. Jubilant Radiopharma Latest Developments
Table 90. Cardinal Health Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 91. Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 92. Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cardinal Health Main Business
Table 94. Cardinal Health Latest Developments
Table 95. IBA Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 96. IBA Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 97. IBA Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. IBA Main Business
Table 99. IBA Latest Developments
Table 100. Sumitomo Heavy Industries Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 101. Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 102. Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Sumitomo Heavy Industries Main Business
Table 104. Sumitomo Heavy Industries Latest Developments
Table 105. Sinotau Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 106. Sinotau Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 107. Sinotau Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Sinotau Main Business
Table 109. Sinotau Latest Developments
Table 110. Nueclear Healthcare Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 111. Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 112. Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Nueclear Healthcare Main Business
Table 114. Nueclear Healthcare Latest Developments
Table 115. DC Pharma Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 116. DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 117. DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. DC Pharma Main Business
Table 119. DC Pharma Latest Developments
Table 1. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radiopharmaceuticals for PET and SPECT Imaging Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Positron Emitters
Table 4. Major Players of Gamma Emitters
Table 5. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Cyclotron-produced
Table 9. Major Players of Reactor/Generator-produced
Table 10. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Produced (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Produced (2021-2026) & ($ millions)
Table 12. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Produced (2021-2026)
Table 13. Major Players of High Specific Activity
Table 14. Major Players of Low Specific Activity
Table 15. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Specific Activity (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Specific Activity (2021-2026) & ($ millions)
Table 17. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Specific Activity (2021-2026)
Table 18. Radiopharmaceuticals for PET and SPECT Imaging Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Table 21. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Player (2021-2026)
Table 23. Radiopharmaceuticals for PET and SPECT Imaging Key Players Head office and Products Offered
Table 24. Radiopharmaceuticals for PET and SPECT Imaging Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Table 29. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Country (2021-2026)
Table 33. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Table 35. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Table 37. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Table 39. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Country (2021-2026)
Table 43. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals for PET and SPECT Imaging
Table 49. Key Market Challenges & Risks of Radiopharmaceuticals for PET and SPECT Imaging
Table 50. Key Industry Trends of Radiopharmaceuticals for PET and SPECT Imaging
Table 51. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. ANSTO Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 56. ANSTO Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 57. ANSTO Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. ANSTO Main Business
Table 59. ANSTO Latest Developments
Table 60. Rosatom Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 61. Rosatom Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 62. Rosatom Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Rosatom Main Business
Table 64. Rosatom Latest Developments
Table 65. Eckert & Ziegler Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 66. Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 67. Eckert & Ziegler Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Eckert & Ziegler Main Business
Table 69. Eckert & Ziegler Latest Developments
Table 70. CNNC Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 71. CNNC Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 72. CNNC Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. CNNC Main Business
Table 74. CNNC Latest Developments
Table 75. Curium Pharma Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 76. Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 77. Curium Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Curium Pharma Main Business
Table 79. Curium Pharma Latest Developments
Table 80. GE HealthCare Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 81. GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 82. GE HealthCare Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. GE HealthCare Main Business
Table 84. GE HealthCare Latest Developments
Table 85. Jubilant Radiopharma Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 86. Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 87. Jubilant Radiopharma Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Jubilant Radiopharma Main Business
Table 89. Jubilant Radiopharma Latest Developments
Table 90. Cardinal Health Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 91. Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 92. Cardinal Health Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cardinal Health Main Business
Table 94. Cardinal Health Latest Developments
Table 95. IBA Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 96. IBA Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 97. IBA Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. IBA Main Business
Table 99. IBA Latest Developments
Table 100. Sumitomo Heavy Industries Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 101. Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 102. Sumitomo Heavy Industries Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Sumitomo Heavy Industries Main Business
Table 104. Sumitomo Heavy Industries Latest Developments
Table 105. Sinotau Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 106. Sinotau Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 107. Sinotau Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Sinotau Main Business
Table 109. Sinotau Latest Developments
Table 110. Nueclear Healthcare Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 111. Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 112. Nueclear Healthcare Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Nueclear Healthcare Main Business
Table 114. Nueclear Healthcare Latest Developments
Table 115. DC Pharma Details, Company Type, Radiopharmaceuticals for PET and SPECT Imaging Area Served and Its Competitors
Table 116. DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Product Offered
Table 117. DC Pharma Radiopharmaceuticals for PET and SPECT Imaging Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. DC Pharma Main Business
Table 119. DC Pharma Latest Developments
LIST OF FIGURES
Figure 1. Radiopharmaceuticals for PET and SPECT Imaging Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radiopharmaceuticals for PET and SPECT Imaging Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radiopharmaceuticals for PET and SPECT Imaging Sales Market Share by Country/Region (2025)
Figure 8. Radiopharmaceuticals for PET and SPECT Imaging Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type in 2025
Figure 10. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Produced in 2025
Figure 11. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Specific Activity in 2025
Figure 12. Radiopharmaceuticals for PET and SPECT Imaging in Hospital
Figure 13. Global Radiopharmaceuticals for PET and SPECT Imaging Market: Hospital (2021-2026) & ($ millions)
Figure 14. Radiopharmaceuticals for PET and SPECT Imaging in Medical Imaging Center
Figure 15. Global Radiopharmaceuticals for PET and SPECT Imaging Market: Medical Imaging Center (2021-2026) & ($ millions)
Figure 16. Radiopharmaceuticals for PET and SPECT Imaging in Other
Figure 17. Global Radiopharmaceuticals for PET and SPECT Imaging Market: Other (2021-2026) & ($ millions)
Figure 18. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application in 2025
Figure 19. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Player in 2025
Figure 20. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Figure 21. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 22. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 23. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 25. Americas Radiopharmaceuticals for PET and SPECT Imaging Value Market Share by Country in 2025
Figure 26. United States Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region in 2025
Figure 31. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Figure 32. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Figure 33. China Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 37. India Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Country in 2025
Figure 40. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Figure 41. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Figure 42. Germany Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 43. France Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 56. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 57. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 59. United States Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 60. Canada Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 61. Mexico Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 62. Brazil Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 63. China Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 64. Japan Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 65. Korea Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 67. India Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 68. Australia Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 69. Germany Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 70. France Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 71. UK Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 72. Italy Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 73. Russia Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 74. Egypt Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 75. South Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 76. Israel Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 77. Turkey Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 78. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 1. Radiopharmaceuticals for PET and SPECT Imaging Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radiopharmaceuticals for PET and SPECT Imaging Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radiopharmaceuticals for PET and SPECT Imaging Sales Market Share by Country/Region (2025)
Figure 8. Radiopharmaceuticals for PET and SPECT Imaging Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type in 2025
Figure 10. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Produced in 2025
Figure 11. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Specific Activity in 2025
Figure 12. Radiopharmaceuticals for PET and SPECT Imaging in Hospital
Figure 13. Global Radiopharmaceuticals for PET and SPECT Imaging Market: Hospital (2021-2026) & ($ millions)
Figure 14. Radiopharmaceuticals for PET and SPECT Imaging in Medical Imaging Center
Figure 15. Global Radiopharmaceuticals for PET and SPECT Imaging Market: Medical Imaging Center (2021-2026) & ($ millions)
Figure 16. Radiopharmaceuticals for PET and SPECT Imaging in Other
Figure 17. Global Radiopharmaceuticals for PET and SPECT Imaging Market: Other (2021-2026) & ($ millions)
Figure 18. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application in 2025
Figure 19. Global Radiopharmaceuticals for PET and SPECT Imaging Revenue Market Share by Player in 2025
Figure 20. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Figure 21. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 22. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 23. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size 2021-2026 ($ millions)
Figure 25. Americas Radiopharmaceuticals for PET and SPECT Imaging Value Market Share by Country in 2025
Figure 26. United States Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region in 2025
Figure 31. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Figure 32. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Figure 33. China Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 37. India Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Country in 2025
Figure 40. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Figure 41. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Figure 42. Germany Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 43. France Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Radiopharmaceuticals for PET and SPECT Imaging Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 56. APAC Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 57. Europe Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 59. United States Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 60. Canada Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 61. Mexico Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 62. Brazil Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 63. China Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 64. Japan Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 65. Korea Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 67. India Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 68. Australia Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 69. Germany Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 70. France Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 71. UK Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 72. Italy Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 73. Russia Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 74. Egypt Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 75. South Africa Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 76. Israel Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 77. Turkey Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
Figure 78. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Radiopharmaceuticals for PET and SPECT Imaging Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Radiopharmaceuticals for PET and SPECT Imaging Market Size 2027-2032 ($ millions)
